Medical Science Liaison (MSL) Hematology
Alpha Clinical Development, Poland, ME, United States
Position Summary
Our client is seeking an experienced Medical Science Liaison (MSL) to serve as a key scientific resource in the field, with a focus on supporting ongoing Phase III clinical trials. The MSL will act as a bridge between the organization and external medical experts, including Key Opinion Leaders (KOLs), investigators, and healthcare professionals. This role will focus on hematologic malignancies, particularly Acute Promyelocytic Leukemia (APML), and will play a critical role in scientific exchange, stakeholder engagement, and dissemination of clinical insights. This role involves approximately 40% of travel. The contract is open-ended for the duration of the project, with full engagement expected across the entire project timeline.
Key Responsibilities
Serve as a scientific liaison between the organization and KOLs, investigators, and healthcare professionals (HCPs)
Engage with KOLs and study investigators to discuss clinical data, study progress, and scientific updates
Provide medical and scientific support for ongoing Phase III clinical trials
Support clinical trial sites with protocol education, disease awareness, and non-promotional scientific guidance
Respond to complex scientific and medical inquiries related to APML and investigational therapies
Collect and communicate field insights, clinical feedback, and unmet medical needs to internal stakeholders
Facilitate scientific exchange initiatives and enhance study awareness within the assigned region
Collaborate cross-functionally with clinical, regulatory, and medical affairs teams to ensure aligned communication
Support site identification, investigator engagement, and Investigator-Sponsored Trials (ISTs)
Maintain awareness of pharmacovigilance processes and support safety reporting activities as required
Qualifications & Profile
Advanced degree (MD, PharmD, or PhD) in a relevant scientific or medical discipline
5 - 8 years of industry experience, including direct MSL or field-based Medical Affairs roles
Demonstrated experience supporting Phase III clinical trials
Strong background in hematologic malignancies or rare hematology; APML experience preferred
In-depth understanding of clinical research, ICH-GCP, and regulatory environment
Strong communication, stakeholder engagement, and analytical skills
Ability to work independently and collaboratively in a cross-functional environment
#J-18808-Ljbffr
Our client is seeking an experienced Medical Science Liaison (MSL) to serve as a key scientific resource in the field, with a focus on supporting ongoing Phase III clinical trials. The MSL will act as a bridge between the organization and external medical experts, including Key Opinion Leaders (KOLs), investigators, and healthcare professionals. This role will focus on hematologic malignancies, particularly Acute Promyelocytic Leukemia (APML), and will play a critical role in scientific exchange, stakeholder engagement, and dissemination of clinical insights. This role involves approximately 40% of travel. The contract is open-ended for the duration of the project, with full engagement expected across the entire project timeline.
Key Responsibilities
Serve as a scientific liaison between the organization and KOLs, investigators, and healthcare professionals (HCPs)
Engage with KOLs and study investigators to discuss clinical data, study progress, and scientific updates
Provide medical and scientific support for ongoing Phase III clinical trials
Support clinical trial sites with protocol education, disease awareness, and non-promotional scientific guidance
Respond to complex scientific and medical inquiries related to APML and investigational therapies
Collect and communicate field insights, clinical feedback, and unmet medical needs to internal stakeholders
Facilitate scientific exchange initiatives and enhance study awareness within the assigned region
Collaborate cross-functionally with clinical, regulatory, and medical affairs teams to ensure aligned communication
Support site identification, investigator engagement, and Investigator-Sponsored Trials (ISTs)
Maintain awareness of pharmacovigilance processes and support safety reporting activities as required
Qualifications & Profile
Advanced degree (MD, PharmD, or PhD) in a relevant scientific or medical discipline
5 - 8 years of industry experience, including direct MSL or field-based Medical Affairs roles
Demonstrated experience supporting Phase III clinical trials
Strong background in hematologic malignancies or rare hematology; APML experience preferred
In-depth understanding of clinical research, ICH-GCP, and regulatory environment
Strong communication, stakeholder engagement, and analytical skills
Ability to work independently and collaboratively in a cross-functional environment
#J-18808-Ljbffr